Blog GreenLight Biosciences Blog November 9, 2020 –– Blog Breaking the Vaccine Production Bottleneck: How to make a Messenger RNA vaccine GreenLight Biosciences is working on a Messenger RNA vaccine. In this piece, the team explains why a Messenger RNA vaccine is so vital and how to make it. Read More May 27, 2021 –– Blog Sustaining Ladybug Life May 22, 2021 –– Blog The Economist: RNA for Bees and Crops May 20, 2021 –– Blog Protecting honeybees from the Varroa destructor mite May 20, 2021 –– Blog GreenLight acquires Bayer’s topical RNA Intellectual Property portfolio April 15, 2021 –– Blog GenEdge: GreenLight Strives for Global RNA Equity April 11, 2021 –– Blog The National: Africa needs to be self-reliant in vaccine production April 7, 2021 –– Blog Amin Khan welcomed as Chief Scientific Officer, Human Health April 1, 2021 –– Blog Financial Times: How to vaccinate the world March 29, 2021 –– Blog GreenLight partners with Fraunhofer IME March 26, 2021 –– Blog A blueprint to vaccinate the world March 23, 2021 –– Blog The Economist: Novel vaccines performed well March 17, 2021 –– Blog Nature: Innovators target vaccines for variants March 9, 2021 –– Blog BioSpace: Feasibility study for powder form of Covid vaccine March 9, 2021 –– Blog Feasibility Arrangement for shelf-stable powder form of COVID-19 Vaccine Candidate March 3, 2021 –– Blog Vox: Lipid nanoparticles are essential to Covid vaccines March 3, 2021 –– Blog Mark Singleton welcomed as lead for plant health innovation February 27, 2021 –– Blog CNN: Critical component for Covid-19 vaccines is in short supply February 21, 2021 –– Blog Washington Post: scarcity of biotech ingredients February 11, 2021 –– Blog Elemental: All about mRNA February 6, 2021 –– Blog The Economist: Covid-19 vaccine resource difficulties February 4, 2021 –– Blog Business Insider: GreenLight named as one of six biotechs VCs are watching January 26, 2021 –– Blog Financial Times: If Covid vaccines stop working, how quickly can drugmakers respond? January 22, 2021 –– Blog Business Journal: Boston firms developing Covid vaccines January 15, 2021 –– Blog STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines January 13, 2021 –– Blog Financial Times: Get vaccine new variant ready January 12, 2021 –– Blog Mail Online: Vaccine roll out issues January 12, 2021 –– Blog Financial Times: Vaccine makers race to fix vaccine supply issues December 11, 2020 –– Blog Five Question Friday: Archie Mathura Meet Archie, December’s Question Friday participant! Archie is GreenLight’s corporate controller, where she supports the company’s accounting, financial reporting, taxes and payroll programs. December 9, 2020 –– Blog Technology Review: What are the Pfizer covid-19 vaccine ingredients? December 4, 2020 –– Blog Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped December 3, 2020 –– Blog Investors Business Daily: Vaccine manufacturing challenge December 1, 2020 –– Blog #WFH Series: Elisha Fielding Up next in our work from home series is Elisha Fielding, Ph.D., Senior Scientist, Biochemist at GreenLight. Elisha shares her work from home hacks and how she stays connected to colleagues during this time. Check out Elisha’s full responses below. November 25, 2020 –– Blog CNBC: The challenges of Covid-19 vaccine production for the masses November 25, 2020 –– Blog BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing November 20, 2020 –– Blog Wired: Manufacturing enough Covid-19 vaccine is a logistical nightmare November 17, 2020 –– Blog #WFH Series: Evelien Van Ekert This week, meet Evelien Van Ekert, Ph.D., Scientist III, Crop Protection at GreenLight. Evelien shares her work from home tips, some special art from her kids, and ways to stay connected to coworkers. Read more below! November 15, 2020 –– Blog Daily Mail: Suppliers of vaccine materials do not have capacity November 13, 2020 –– Blog Five Question Friday: Upendra Devisetty Meet Upendra, this month’s 5 Question Friday participant! Upendra is a data scientist at GreenLight, working on both crop protection and human health projects. He enjoys using his skills in data science and bioinformatics to help contribute to multiple projects simultaneously. November 12, 2020 –– Blog Metro: How the Covid vaccine could transform the world November 12, 2020 –– Blog Fortune: If we don’t vaccinate the world quickly, our COVID efforts will be a waste November 9, 2020 –– Blog How to make a messenger RNA vaccine: Inside the RNA manufacturing process Messenger RNA vaccines are a new category. Check out how messenger RNA manufacturing works and how it is made into a vaccine November 9, 2020 –– Blog The differences between the COVID-19 Vaccines: From Messenger RNA to Viral Vectors There are a lot of different types of vaccines being developed to get us past the COVID-19 pandemic, including GreenLight’s mRNA efforts. Here’s our overview of the types of vaccines. November 9, 2020 –– Blog Breaking the Vaccine Production Bottleneck: How to make a Messenger RNA vaccine GreenLight Biosciences is working on a Messenger RNA vaccine. In this piece, the team explains why a Messenger RNA vaccine is so vital and how to make it. November 3, 2020 –– Blog #WFH Series: Matt Moura This week in the GreenLight #WFH series, we connected with Matthew Moura, Ph.D., Senior Scientist, Pathway Engineer at GreenLight. Check out Matthew’s tips and tricks for his home office, some memorable items for motivation, and ways to stay connected with co-workers. October 21, 2020 –– Blog Unherd: Will a vaccine stop Covid? October 20, 2020 –– Blog #WFH Series: Kestrel McCorkle This week, we’re kicking off our work from home series with Kestrel McCorkle, Ph.D., Scientist III, Crop Protection. Check out a few tips, tricks, and even board games below! October 9, 2020 –– Blog Five Question Friday: Oscar Pardo, Ph.D. Meet this month’s 5 Question Friday spotlight – Oscar Pardo, an engineer on the Process Science team. Oscar works on process development of GreenLight’s cell-free reaction in plant and human health projects. September 15, 2020 –– Blog GreenLight Biosciences Receives $3.3 Million Grant BOSTON, Sept. 15, 2020 — GreenLight Biosciences has received a $3.3 million grant from the Bill & Melinda Gates Foundation to develop new mRNA-based gene therapies for Sickle Cell Disease and other global health challenges. September 4, 2020 –– Blog Five Question Friday: Ethann Barnes This month, Ethann Barnes, Biology Data Management Scientist, answers five questions about his experience with the company, his background and hobbies. August 7, 2020 –– Blog Five Question Friday: Jo Tang This month, Jo Tang, Project Manager, answers five questions about her experience with the company, her background and hobbies. July 24, 2020 –– Blog Agricultural Sustainability: Consumer Survey A survey we conducted on farming practices found that consumers remain optimistic and are open to new ways to grow safe and healthy food sustainably. April 27, 2020 –– Blog The New Normal I was recently on a Zoom call with hundreds of young people explaining our company’s large-scale manufacturing process for a SARS-CoV2 vaccine. They all wanted to know one thing: how can we get back to the way things were? How do we get back to normal? January 28, 2020 –– Blog If the Bugs Go, We Go In the last week, a group of Australian and Chinese scientists published a review article describing the results of a number of studies conducted by approximately 50 research groups around the globe over the last decade. May 6, 2017 –– Blog The Economist: Cell-free biotech will make for better products Join the GreenLight Revolution Learn more about how GreenLight Biosciences is enabling innovative technologies to protect the health of people and the planet. We are always looking to meet new partners, new colleagues or anyone interested to learn more about RNA. CONTACT US JOIN OUR TEAM
March 9, 2021 –– Blog Feasibility Arrangement for shelf-stable powder form of COVID-19 Vaccine Candidate
January 26, 2021 –– Blog Financial Times: If Covid vaccines stop working, how quickly can drugmakers respond?
January 15, 2021 –– Blog STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines
December 11, 2020 –– Blog Five Question Friday: Archie Mathura Meet Archie, December’s Question Friday participant! Archie is GreenLight’s corporate controller, where she supports the company’s accounting, financial reporting, taxes and payroll programs.
December 4, 2020 –– Blog Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped
December 1, 2020 –– Blog #WFH Series: Elisha Fielding Up next in our work from home series is Elisha Fielding, Ph.D., Senior Scientist, Biochemist at GreenLight. Elisha shares her work from home hacks and how she stays connected to colleagues during this time. Check out Elisha’s full responses below.
November 17, 2020 –– Blog #WFH Series: Evelien Van Ekert This week, meet Evelien Van Ekert, Ph.D., Scientist III, Crop Protection at GreenLight. Evelien shares her work from home tips, some special art from her kids, and ways to stay connected to coworkers. Read more below!
November 13, 2020 –– Blog Five Question Friday: Upendra Devisetty Meet Upendra, this month’s 5 Question Friday participant! Upendra is a data scientist at GreenLight, working on both crop protection and human health projects. He enjoys using his skills in data science and bioinformatics to help contribute to multiple projects simultaneously.
November 12, 2020 –– Blog Fortune: If we don’t vaccinate the world quickly, our COVID efforts will be a waste
November 9, 2020 –– Blog How to make a messenger RNA vaccine: Inside the RNA manufacturing process Messenger RNA vaccines are a new category. Check out how messenger RNA manufacturing works and how it is made into a vaccine
November 9, 2020 –– Blog The differences between the COVID-19 Vaccines: From Messenger RNA to Viral Vectors There are a lot of different types of vaccines being developed to get us past the COVID-19 pandemic, including GreenLight’s mRNA efforts. Here’s our overview of the types of vaccines.
November 9, 2020 –– Blog Breaking the Vaccine Production Bottleneck: How to make a Messenger RNA vaccine GreenLight Biosciences is working on a Messenger RNA vaccine. In this piece, the team explains why a Messenger RNA vaccine is so vital and how to make it.
November 3, 2020 –– Blog #WFH Series: Matt Moura This week in the GreenLight #WFH series, we connected with Matthew Moura, Ph.D., Senior Scientist, Pathway Engineer at GreenLight. Check out Matthew’s tips and tricks for his home office, some memorable items for motivation, and ways to stay connected with co-workers.
October 20, 2020 –– Blog #WFH Series: Kestrel McCorkle This week, we’re kicking off our work from home series with Kestrel McCorkle, Ph.D., Scientist III, Crop Protection. Check out a few tips, tricks, and even board games below!
October 9, 2020 –– Blog Five Question Friday: Oscar Pardo, Ph.D. Meet this month’s 5 Question Friday spotlight – Oscar Pardo, an engineer on the Process Science team. Oscar works on process development of GreenLight’s cell-free reaction in plant and human health projects.
September 15, 2020 –– Blog GreenLight Biosciences Receives $3.3 Million Grant BOSTON, Sept. 15, 2020 — GreenLight Biosciences has received a $3.3 million grant from the Bill & Melinda Gates Foundation to develop new mRNA-based gene therapies for Sickle Cell Disease and other global health challenges.
September 4, 2020 –– Blog Five Question Friday: Ethann Barnes This month, Ethann Barnes, Biology Data Management Scientist, answers five questions about his experience with the company, his background and hobbies.
August 7, 2020 –– Blog Five Question Friday: Jo Tang This month, Jo Tang, Project Manager, answers five questions about her experience with the company, her background and hobbies.
July 24, 2020 –– Blog Agricultural Sustainability: Consumer Survey A survey we conducted on farming practices found that consumers remain optimistic and are open to new ways to grow safe and healthy food sustainably.
April 27, 2020 –– Blog The New Normal I was recently on a Zoom call with hundreds of young people explaining our company’s large-scale manufacturing process for a SARS-CoV2 vaccine. They all wanted to know one thing: how can we get back to the way things were? How do we get back to normal?
January 28, 2020 –– Blog If the Bugs Go, We Go In the last week, a group of Australian and Chinese scientists published a review article describing the results of a number of studies conducted by approximately 50 research groups around the globe over the last decade.